Email This Article

FDA Wants More Data From Celgene
By Althea Chang
11/15/05 - 12:53 PM EST
The company wants to get Thalomid approved for treating blood cancer.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,394.11 1,104.56 2,189.05 34.52
Oil *
76.47
UP
5.21
DOWN
1.42
DOWN
5.30
DOWN
0.31
10 Yr
3.45%
SPDR Gold
113.42
+0.05%
-0.13%
-0.24%
-0.89%
Data delayed 20 minutes

Brokerage Partners